Zobrazeno 1 - 10
of 26
pro vyhledávání: '"R. Z. Lewanczuk"'
Publikováno v:
Journal of Obesity, Vol 2011 (2011)
Antiobesity pharmacotherapy and programs/providers that possess weight management expertise are not commonly used by physicians. The underlying reasons for this are not known. We performed a cross-sectional study in 33 Canadian medical practices (36
Externí odkaz:
https://doaj.org/article/174f0591aab94222866e2cc56acf24b4
Autor:
N N, Ladhani, S R, Majumdar, J A, Johnson, R T, Tsuyuki, R Z, Lewanczuk, R, Spooner, S H, Simpson
Publikováno v:
Diabetic medicine : a journal of the British Diabetic Association. 29(11)
To determine the impact of adding pharmacists to primary care teams on predicted 10-year risk of cardiovascular events in patients with Type 2 diabetes without established cardiovascular disease.This was a pre-specified secondary analysis of randomiz
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::aa51ddc4f52e8fc3960c12ebd16a2f6e
https://pubmed.ncbi.nlm.nih.gov/22486226
https://pubmed.ncbi.nlm.nih.gov/22486226
Publikováno v:
Journal of Cardiovascular Pharmacology. 23:S23-S26
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5bcaab357c7fcdb9a48f2f14d21a1b05
https://doi.org/10.1097/00005344-199406032-00006
https://doi.org/10.1097/00005344-199406032-00006
Publikováno v:
Journal of Obesity
Antiobesity pharmacotherapy and programs/providers that possess weight management expertise are not commonly used by physicians. The underlying reasons for this are not known. We performed a cross-sectional study in 33 Canadian medical practices (36
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cef679ba71159300f3a2e37b440813aa
https://pubmed.ncbi.nlm.nih.gov/21113310
https://pubmed.ncbi.nlm.nih.gov/21113310
Autor:
R. Z. Lewanczuk, P. K. T. Pang
Publikováno v:
American Journal of Hypertension. 3:189S-194S
Circulating substances that increase intracellular calcium, and other circulating substances that increase blood pressure, have been described in hypertensive animals and humans. In this study, we report the existence of a factor of the plasma of spo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f84496737609d9cd4e90b2ae54a0bc5b
https://doi.org/10.1093/ajh/3.8.189
https://doi.org/10.1093/ajh/3.8.189
Autor:
R, Cheung, R Z, Lewanczuk, N W, Rodger, M W, Huff, P, Oddou-Stock, F, Botteri, E, Pecher, N, Muirhead
Publikováno v:
International journal of clinical practice. 53(8)
The study compared valsartan 80 mg or 160 mg o.d. with captopril 25 mg t.i.d. or placebo on plasma lipids in normotensive and treated hypertensive patients with type II diabetes and microalbuminuria. One hundred and twenty-two adult outpatients were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bbab1ff1e7924f07808c49f204bf70c5
https://pubmed.ncbi.nlm.nih.gov/10692751
https://pubmed.ncbi.nlm.nih.gov/10692751
Autor:
F A, McAlister, R Z, Lewanczuk
Publikováno v:
Canadian journal of surgery. Journal canadien de chirurgie. 41(4)
To determine the frequency of nonfunctioning adrenal masses in patients with primary hyperaldosteronism.A case series.A tertiary care hypertension clinic.Twenty-seven consecutive patients with primary hyperaldosteronism.Blood pressure, serum electrol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4eb7ae764ba244ae034a9f6948ae5d6d
https://pubmed.ncbi.nlm.nih.gov/9711163
https://pubmed.ncbi.nlm.nih.gov/9711163
Publikováno v:
The Canadian journal of cardiology. 12(9)
To review the factors contributing to treatment resistance in hypertensive patients and assess the evidence from therapeutic trials in these patients.A MEDLINE search using the words 'resistant hypertension', 'refractory hypertension' and 'treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::99d09febe52a84815214e3c26f476404
https://pubmed.ncbi.nlm.nih.gov/8842136
https://pubmed.ncbi.nlm.nih.gov/8842136
Publikováno v:
The Journal of clinical endocrinology and metabolism. 81(1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69c4e2e51bf32440233fdbbd6926e31e
https://pubmed.ncbi.nlm.nih.gov/8550743
https://pubmed.ncbi.nlm.nih.gov/8550743
Publikováno v:
Journal of cardiovascular pharmacology. 23
Parathyroid hypertensive factor (PHF) has been purified from two sources of material: plasma of spontaneously hypertensive rats (SHRs) and culture medium from organ culture of SHR parathyroid glands. Chromatographic characteristics of PHF from these
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e4c7ca6c6ec6980527c54b4bc4b03462
https://pubmed.ncbi.nlm.nih.gov/7518547
https://pubmed.ncbi.nlm.nih.gov/7518547